Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome-Reference-Cited by-同舟云学术

Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome

Published:2013-10 Issue:9 Volume:7 Page:717-722
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

García-Bosch Orlando,Gisbert Javier P.,Cañas-Ventura Àlex,Merino Olga,Cabriada José L.,García-Sánchez Valle,Gutiérrez Ana,Nos Pilar,Peñalva Mireia,Hinojosa Joaquin,García-Planella Esther,Muñoz Fernando,Calvet Xavier,Panés Julián

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/7/9/717/1175923/7-9-717.pdf

Reference10 articles.

1. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study;Faubion;Gastroenterology,2001

2. Systematic review: costs of ulcerative colitis in western countries;Cohen;Aliment Pharmacol Ther,2010

3. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

4. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study;Järnerot;Gastroenterology,2005

5. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial;Reinisch;Gut,2011

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection strategy of second-line biologic therapies in adult patients with ulcerative colitis following prior biologic treatment failure: Systematic review and meta-analysis;Pharmacological Research;2024-04

2. Albumin change predicts failure in ulcerative colitis treated with adalimumab;PLOS ONE;2024-01-02

3. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry;Therapeutic Advances in Gastroenterology;2024-01

4. Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis;Crohn's & Colitis 360;2024-01-01

5. Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study;Journal of Crohn's and Colitis;2023-09-11